The risk of metabolic syndrome according to the white blood cell count in apparently healthy Korean adults

Yonsei Medical Journal

Volumn 54, Issue 3, 2013, Pages 615-620

  Jung, Chan Hee ^a   Lee, Won Young ^b   Kim, Bo Yeon ^a   Park, Se Eun ^b   Rhee, Eun Jung ^b   Park, Cheol Young ^b   Oh, Ki Won ^b   Mok, Ji Oh ^a   Kim, Chul Hee ^a   Park, Sung Woo ^b   Kim, Sun Woo ^b   Kang, Sung Koo ^a  

^a Soonchunhyang University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Inflammation; Metabolic syndrome; White blood cell count

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MERCURY SPHYGMOMANOMETER; METABOLIC SYNDROME X; PREVALENCE; RETROSPECTIVE STUDY; RISK; SYSTOLIC BLOOD PRESSURE;

INFLAMMATION; METABOLIC SYNDROME; WHITE BLOOD CELL COUNT;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84875880794     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2013.54.3.615     Document Type: Article

References (34)

1. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
2. Koenig W. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. Int J Cardiol 2005;98:199-206.
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
4. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279:1477-82.
5. Wang YY, Lin SY, Liu PH, Cheung BM, Lai WA. Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications 2004;18: 322-7.
6. Yen ML, Yang CY, Yen BL, Ho YL, Cheng WC, Bai CH. Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men. Int J Cardiol 2006;110:191-8.
7. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7.
8. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Mehta R, Franco A, Olaiz G, et al. The metabolic syndrome: a concept hard to define. Arch Med Res 2005;36:223-31.
9. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-7.
10. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002;25:2016-21.
11. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992;267:1253-6.
12. Nagasawa N, Tamakoshi K, Yatsuya H, Hori Y, Ishikawa M, Mu-rata C, et al. Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circ J 2004;68:892-7.
13. Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations. Am J Hypertens 2006;19:339-45.
14. Oda E, Kawai R. The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women. Intern Med 2009;48:1127-34.
15. Odagiri K, Uehara A, Mizuta I, Yamamoto M, Kurata C. Longitudinal study on white blood cell count and the incidence of metabolic syndrome. Intern Med 2011;50:2491-8.
16. Chen W, Srinivasan SR, Xu J, Berenson GS. Black-white divergence in the relation of white blood cell count to metabolic syndrome in preadolescents, adolescents, and young adults: the Boga-lusa Heart Study. Diabetes Care 2010;33:2474-6.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112: 2735-52.
18. Grau AJ, Buggle F, Becher H, Werle E, Hacke W. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 1996;82:245-55.
19. Lao XQ, Neil Thomas G, Jiang C, Zhang W, Adab P, Lam TH, et al. White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis 2008;201:418-24.
20. Kim DJ, Noh JH, Lee BW, Choi YH, Chung JH, Min YK, et al. The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J Korean Med Sci 2008;23:193-8.
21. Fernández-Real JM, Ricart W. Insulin resistance and infammation in an evolutionary perspective: the contribution of cytokine geno-type/phenotype to thriftiness. Diabetologia 1999;42:1367-74.
22. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleu-kin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocri-nol Metab 1997;82:4196-200.
23. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
24. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001;86:1154-9.
25. Sims E. Humoral factors. Oxford: IRL Press; 1993. p.1-373.
26. Targher G, Seidell JC, Tonoli M, Muggeo M, De Sandre G, Cigo-lini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 1996;239:435-41.
27. Kawada T. Smoking-induced leukocytosis can persist after cessation of smoking. Arch Med Res 2004;35:246-50.
28. Corre F, Lellouch J, Schwartz D. Smoking and leucocyte-counts. Results of an epidemiological survey. Lancet 1971;2:632-4.
29. Ford ES. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 2002;155:57-64.
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
31. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Do-nato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-5.
32. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50.
33. Wong ND, Sciammarella MG, Polk D, Gallagher A, Miranda-Peats L, Whitcomb B, et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003;41:1547-53.
34. Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yama-saki M, et al. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 2005;47:126-35.